home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

37 rows where docket_id = "FDA-2017-D-0085" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 3

  • 2017 28
  • 2022 8
  • 2023 1

document_type 3

  • Supporting & Related Material 31
  • Notice 4
  • Other 2

agency_id 1

  • FDA 37
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2017-D-0085-0051 FDA None FDA-2017-D-0085 Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals Notice Notice of Approval 2023-02-14T05:00:00Z 2023 2 2023-02-14T05:00:00Z   2023-02-14T15:00:41Z 2023-03073 0 0 090000648569352e
FDA-2017-D-0085-0044 FDA None FDA-2017-D-0085 Best Practices for Convening a GRAS Panel; Guidance for Industry; Availability Notice Notice of Availability 2022-12-22T05:00:00Z 2022 12 2022-12-22T05:00:00Z   2022-12-22T14:39:30Z 2022-27714 0 0 090000648554882e
FDA-2017-D-0085-0045 FDA None FDA-2017-D-0085 Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance Other Guidance 2022-12-21T05:00:00Z 2022 12 2022-12-21T05:00:00Z   2024-11-12T23:49:43Z   1 0 0900006485549dab
FDA-2017-D-0085-0048 FDA None FDA-2017-D-0085 Reference-30-GRAS Notices Search Results Common Use In Food - Re: Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance Supporting & Related Material Background Material 2022-12-21T05:00:00Z 2022 12     2022-12-21T21:13:51Z   0 0 0900006485549f5d
FDA-2017-D-0085-0046 FDA None FDA-2017-D-0085 Final Guidance - Reference List - Re: Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance Supporting & Related Material Background Material 2022-12-21T05:00:00Z 2022 12     2022-12-21T21:13:02Z   0 0 09000064855494a0
FDA-2017-D-0085-0047 FDA None FDA-2017-D-0085 Reference-29-Memorandum-November 4, 2010-Linda Kahl - Substances that Are Generally Recognized as Safe (GRAS); Experience with GRAS Notices - Re: Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance Supporting & Related Material Background Material 2022-12-21T05:00:00Z 2022 12     2022-12-21T21:13:35Z   0 0 09000064855494a1
FDA-2017-D-0085-0049 FDA None FDA-2017-D-0085 Reference-31-OECD 2017-Guidance on Grouping of Chemicals- Re: Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance Supporting & Related Material Background Material 2022-12-21T05:00:00Z 2022 12     2022-12-21T21:14:18Z   0 0 0900006485549f5e
FDA-2017-D-0085-0050 FDA None FDA-2017-D-0085 Reference-32-Ball 2016-Toward Good Read-Across Practice (GRAP) Guidance- Re: Best Practices for Convening a GRAS Panel: Guidance for Industry - Final Guidance Supporting & Related Material Background Material 2022-12-21T05:00:00Z 2022 12     2022-12-21T21:14:43Z   0 0 0900006485549f5f
FDA-2017-D-0085-0042 FDA None FDA-2017-D-0085 Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Substances Generally Recognized as Safe: Best Practices for Convening a Generally Recognized as Safe Panel Notice 30 Day Proposed Information Collection 2022-10-27T04:00:00Z 2022 10 2022-10-27T04:00:00Z 2022-11-29T04:59:59Z 2022-12-21T16:18:56Z 2022-23378 0 0 0900006485462764
FDA-2017-D-0085-0017 FDA None FDA-2017-D-0085 Reference-16-Milch-2009-From-individual-preference-construction-group-decisions-framing-effects-group-processes re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:57:27Z   0 0 0900006482cb21a1
FDA-2017-D-0085-0023 FDA None FDA-2017-D-0085 Reference-23-About-FEMA-GRAS-Program re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:57:58Z   0 0 0900006482cb21aa
FDA-2017-D-0085-0028 FDA None FDA-2017-D-0085 Reference-28-Pew-2013-Draft-COI-Guidance-Consideration-FDA re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:58:20Z   0 0 0900006482cb21af
FDA-2017-D-0085-0003 FDA None FDA-2017-D-0085 GUIDANCE -REFERENCE LIST re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:56:17Z   0 0 0900006482cb1e6f
FDA-2017-D-0085-0018 FDA None FDA-2017-D-0085 Reference-17-Jonas-2001-Confirmation-bias-sequential-information-search-after-preliminary-decisions re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:57:32Z   0 0 0900006482cb21a2
FDA-2017-D-0085-0026 FDA None FDA-2017-D-0085 Reference-26-Guyatt-2010-Vexing-problem-guidelines-conflicts-interest-potential-solution re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:58:11Z   0 0 0900006482cb21ad
FDA-2017-D-0085-0025 FDA None FDA-2017-D-0085 Reference-25-Norris-2011-Conflict-interest-clinical-practice-guideline-development-systematic-review re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:58:07Z   0 0 0900006482cb21ac
FDA-2017-D-0085-0011 FDA None FDA-2017-D-0085 Reference-10-IOM-2009-Conflict-Interest-Medical-Research-Education-Practice re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:56:58Z   0 0 0900006482cb219b
FDA-2017-D-0085-0016 FDA None FDA-2017-D-0085 Reference-15-Cheng-Chiou-2008-Framing-effects-group-investment-decision-making-role-group-polarization re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:57:22Z   0 0 0900006482cb21a0
FDA-2017-D-0085-0019 FDA None FDA-2017-D-0085 Reference-18- Mancuso-2014-Effects-cognitive-biases-distributed-team-decision-making re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:57:37Z   0 0 0900006482cb21a3
FDA-2017-D-0085-0024 FDA None FDA-2017-D-0085 Reference-24-Alpert-2004-ACCF-AHA-Codes-Conduct-Human-Studies-Research re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:58:03Z   0 0 0900006482cb21ab
FDA-2017-D-0085-0021 FDA None FDA-2017-D-0085 Reference-20-FDA-2016-Draft-Guidance-Procedures-Evaluating-Appearance-Issues-FDA-Advisory-Committees re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:57:49Z   0 0 0900006482cb21a8
FDA-2017-D-0085-0007 FDA None FDA-2017-D-0085 Reference-06-Croskerry-2002-Achieving-quality-clinical-decision-making-cognitive-strategies-detection-bias re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:56:40Z   0 0 0900006482cb1e73
FDA-2017-D-0085-0005 FDA None FDA-2017-D-0085 Reference-02-Guidance-Frequently-Asked-Questions-About-GRAS re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:56:28Z   0 0 0900006482cb1e71
FDA-2017-D-0085-0012 FDA None FDA-2017-D-0085 Reference-11 NAS-2013-Policy-Committee-Composition-Balance-Conflicts-Interest re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:57:03Z   0 0 0900006482cb219c
FDA-2017-D-0085-0006 FDA None FDA-2017-D-0085 Reference-03-Report-Congressional-Requestors-Food-Safety-FDA-Should-Strengthen-Oversight-GRAS-Ingredients re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:56:35Z   0 0 0900006482cb1e72
FDA-2017-D-0085-0009 FDA None FDA-2017-D-0085 Reference-08-Bazerman-2002-Why-good-accountants-do-bad-audits re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:56:49Z   0 0 0900006482cb1e75
FDA-2017-D-0085-0027 FDA None FDA-2017-D-0085 Reference-27-NCCN-2014-NCCN-Disclosure-Policies-Potential-Conflicts-Interest re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:58:16Z   0 0 0900006482cb21ae
FDA-2017-D-0085-0022 FDA None FDA-2017-D-0085 Reference-21-FDA-2014-Guidance-Public-Availability-Advisory-Committee-Members-Financial-Interest-Information-Waivers re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:57:54Z   0 0 0900006482cb21a9
FDA-2017-D-0085-0014 FDA None FDA-2017-D-0085 Reference-13-van-Ginkel-van-Knippenberg-2012-Group-leadership-shared-task-representations-decision-making-groups re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:57:13Z   0 0 0900006482cb219e
FDA-2017-D-0085-0013 FDA None FDA-2017-D-0085 Reference-12-Pagliari-2001-Potential-influence-small-group-processes-guideline-development re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:57:07Z   0 0 0900006482cb219d
FDA-2017-D-0085-0004 FDA None FDA-2017-D-0085 Reference-01-Guidance-Regulatory-Framework-GRAS-Substances re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:56:22Z   0 0 0900006482cb1e70
FDA-2017-D-0085-0010 FDA None FDA-2017-D-0085 Reference-09-Moore-2010-Conflict-of-interest-intrusion-bias re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:56:53Z   0 0 0900006482cb219a
FDA-2017-D-0085-0008 FDA None FDA-2017-D-0085 Reference-07-Arnott-2006-Cognitive-biases-decision-support-systems-development re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:56:45Z   0 0 0900006482cb1e74
FDA-2017-D-0085-0015 FDA None FDA-2017-D-0085 Reference-14-Tschan-2009-Explicit-reasoning-confirmation-bias-illusory-transactive-memory re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:57:18Z   0 0 0900006482cb219f
FDA-2017-D-0085-0020 FDA None FDA-2017-D-0085 Reference- 19-FDA-2008-Guidance-Procedures-Determining-Conflict-Interest-Eligibility-Participation-FDA-Advisory-Committees re Best Practices for Convening a GRAS Panel: Guidance for Industry Draft Guidance Supporting & Related Material Background Material 2017-11-27T05:00:00Z 2017 11     2017-11-27T21:57:44Z   0 0 0900006482cb21a7
FDA-2017-D-0085-0001 FDA None FDA-2017-D-0085 Guidance: Best Practices for Convening a Generally Recognized as Safe Panel Notice Notice of Availability 2017-11-16T05:00:00Z 2017 11 2017-11-16T05:00:00Z 2018-05-16T03:59:59Z 2018-02-08T02:03:44Z 2017-24845 0 0 0900006482c83776
FDA-2017-D-0085-0002 FDA None FDA-2017-D-0085 Best Practices for Convening a GRAS Panel: Guidance for Industry; Draft Guidance Other Guidance 2017-11-16T05:00:00Z 2017 11 2017-11-16T05:00:00Z   2022-12-21T16:44:12Z   0 0 0900006482c84b3d

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 4520.8ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API